Related Experiment Video
Updated: Jun 14, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
Immunomodulation for type 1 diabetes mellitus
1Division of Endocrinology, Diabetes, and Metabolism, and Diabetes Research Institute, University of Miami, Miller School of Medicine, Miami, FL 33101-6960, USA. skyler@miami.edu
Abstract:
Type 1 diabetes (T1D) is characterised by immune-mediated pancreatic islet beta-cell destruction. The initial immune response engenders secondary and tertiary responses which collectively result in impairment of beta-cell function, progressive destruction of beta-cells and consequent development of T1D. The process is insidious and may evolve over many years, with the overt expression of clinical symptoms becoming apparent only when most beta-cells have been destroyed. Over the last quarter century much investigation has been directed at interdicting the T1D disease process, both during the stage of evolution of the disease and at the time of disease onset. This chapter of the Yearbook of Advanced Technology and Treatments in Diabetes reviews the key articles that have appeared in this field between January 2008 and June 2009.
More Related Videos
Related Concept Videos
Type I Diabetes II: Pathophysiology
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction
Type II Diabetes I: Introduction
Type I Diabetes III: Clinical Manifestations
Diabetes Mellitus: Introduction

